Abstract

Granulosa cell tumor (GCT) is a rare tumor in ovaries, accounts for 2% to 5% of ovarian cancers [1]. The GCT is divided into two categories according to the age of patients, namely AGCT (adult granulosa cell tumor) and JGCT (juvenile granulosa cell tumor) [1]. AGCT patients accounts for 95%, approximately 5% are JGCT [1,6]. The stage at time of diagnosis is the only prognostic factor that is unequivocally related to survival [13]. The overall 10-year survival in early stage is favorable at 75%-90% [13]. Complete tumor removal should always be attempted as primary treatment and a multidisciplinary procedure should be considered for advanced stages [13]. Granulosa cell tumors are well known for late recurrence [13]. As a clinical consequence, lifelong follow-up for all patients with granulosa cell tumors is warranted and should not end after five years [13].